Cargando…
Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study
BACKGROUND: A population of breast cancer patients exists who, for various reasons, never received adjuvant post-operative tamoxifen (TAM). This study was aimed to evaluate the role of late TAM in these patients. METHODS: From 1997 to 2003, patients aged 35 to 75 years, operated more than 2 years pr...
Autores principales: | Veronesi, Andrea, Miolo, GianMaria, Magri, Maria D, Crivellari, Diana, Scalone, Simona, Bidoli, Ettore, Lombardi, Davide |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882922/ https://www.ncbi.nlm.nih.gov/pubmed/20470379 http://dx.doi.org/10.1186/1471-2407-10-205 |
Ejemplares similares
-
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients
por: Miolo, Gianmaria, et al.
Publicado: (2014) -
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
por: Miolo, Gianmaria, et al.
Publicado: (2016) -
The Italian Tamoxifen Prevention Trial
por: Bonanni, B., et al.
Publicado: (1999) -
Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers
por: Miolo, GianMaria, et al.
Publicado: (2009) -
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
por: Muraro, Elena, et al.
Publicado: (2011)